Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-01-07 00:00:00 ET · period of report 2025-01-03 · accession 0001415889-25-001020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-07 | 2025-01-03 | PTCT | Boulding Mark Elliott | EVP AND CLO | A - Grant | $0.00 | +18.0K | 110.4K | +19% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Boulding Mark Elliott | EVP AND CLO | A - Grant | $0.00 | +45.0K | 45.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | A | A | 18,000 | $0.00 | 110,389 | D | — | — | (F1) Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-01-03 | A | A | 45,000 | $0.00 | 45,000 | D | $46.54 · — to 2035-01-02 | 45,000 Common Stock | (F2) This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. |